NYSE$AVD

American Vanguard Corporation · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

American Vanguard reported Q3 2024 results, with non-crop revenues growing by 17% and green solutions revenues increasing by 18% year-over-year. The company reduced debt by $32.5 million and is raising expected annual transformation benefits to $20 million.

American Vanguard reported a decrease in net sales to $118.3 million compared to $149.5 million in the third quarter of 2023. The company's EPS was $(0.92) compared to ($0.01) in the previous year. Despite these challenges, non-crop and green solutions businesses showed strong growth, and the company is making progress with its business transformation, expecting increased annual benefits.

  • Net sales were $118.3 million, which includes the impact of the Dacthal product recall, compared to $149.5 million in Q3 2023.
  • Adjusted EBITDA was $1.8 million, down from $11.4 million in the same quarter last year.
  • EPS was $(0.92), compared to $(0.01) in the third quarter of 2023.
  • The company reduced debt by $32.5 million from the previous quarter.

Headline financials

Total Revenue

$118M

Previous: $150M-20.9%
EPS

-$0.91

Previous: -$0.01-9000.0%
Gross Margin

15.0%

Previous: 29.0%-48.3%
Adjusted EBITDA

$1.8M

No prior period
Capital Expenditures

-$6.11M

Previous: -$8.59M+28.9%
Free Cash Flow

-$31.8M

Previous: -$8.91M-257.3%
Net Income

-$25.7M

Previous: -$325K-7820.6%
Operating Income

-$28.4M

Previous: $4.19M-777.4%
Gross Profit

$17.3M

Previous: $43.1M-59.9%
Cash & Equivalents

$11.9M

Previous: $11.5M+3.0%
Total Assets

$759M

Previous: $803M-5.4%
R&D Expense

$11.2M

Previous: $0.00
Stock-Based Comp

$1.14M

Previous: $1.72M-33.9%

Revenue & EPS history

American Vanguard · Revenue · Quarterly

$118M

Q3 2024-20.9%vs Q3 2023
Beat estimate in 5 of 13 quarters(38%)
ActualEstimate

Revenue by segment

American Vanguard · $150M total across 3 segments · Q3 2023

  • U.S. Crop
    $67.7M-2.0%
  • International
    $62.5M-2.4%
  • U.S. Non-Crop
    $19.3M+1.7%

Forward guidance

The Company reiterated its full year 2024 revenue (down 2% to flat, excluding the product recall charge) and adjusted EBITDA ($40—$50 million) targets.

Tailwinds

  • Full year 2024 revenue target reiterated (down 2% to flat, excluding the product recall charge)
  • Full year 2024 adjusted EBITDA target reiterated ($40-$50 million)
  • Company is focused on returning to consistent free cash flow generation
  • Near-term free cash flow will be allocated towards further deleveraging
  • Medium to long-term free cash flow will be applied to growth opportunities

Headwinds

  • One-time charges associated with business transformation
  • Incurred $8.1 million transformation charge during the quarter
  • Recorded $16.2 million charge associated with the collection and disposal of Dacthal
  • Macroeconomic headwinds
  • Pressure from generics

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

-1.0%

Avg return

Earnings day

-3.0%

Avg return

5 days after

-2.6%

Avg return

30 days after

52%

34 / 65 earnings

Positive

+18.9%

Q4 2015

Best reaction

-34.9%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.4%-1.0%-9.8%
Q4 2025-9.6%-30.9%-24.6%
Q3 2025-0.8%-0.4%-14.9%
Q1 2025-9.2%-8.5%-19.2%
Q4 2024-5.7%+6.2%-20.0%
Q3 2024+2.1%+5.0%-5.7%
Q2 2024-34.9%-28.5%-20.5%
Q1 2024-26.6%-30.6%-30.4%
Q4 2023+15.3%+9.4%+4.5%
Q3 2023+1.1%-12.3%+5.1%
Q2 2023-16.6%-13.1%-24.7%
Q1 2023-12.9%-9.9%-3.1%
Q4 2022+4.9%+5.5%+7.8%
Q3 2022-4.4%-6.6%-4.8%
Q2 2022-18.2%-15.5%-19.8%
Q1 2022+5.6%-4.5%+17.9%
Q4 2021+2.6%+6.5%+24.0%
Q3 2021+4.3%+3.0%-9.2%
Q2 2021-0.7%-6.6%-3.5%
Q1 2021-3.3%-5.8%-14.6%
Q4 2020+2.1%-2.0%-8.6%
Q3 2020+9.2%+8.3%+21.8%
Q2 2020+4.6%+3.0%+1.0%
Q1 2020-1.9%-9.6%-3.1%
Q4 2019-4.6%-9.3%+2.3%
Q3 2019+5.0%+6.4%+8.4%
Q2 2019+5.4%+3.0%+13.8%
Q1 2019-0.3%-8.3%-19.6%
Q4 2018+6.2%-1.1%-2.1%
Q3 2018-5.6%-1.9%-7.5%
Q2 2018-4.2%-9.3%-4.0%
Q1 2018+11.7%+0.9%+10.5%
Q4 2017+16.0%+15.5%+9.8%
Q3 2017-6.1%-10.1%-10.8%
Q2 2017+9.7%+13.1%+10.0%
Q1 2017+10.9%+9.1%+9.4%
Q4 2016-4.0%-6.2%+4.7%
Q3 2016+0.3%+3.3%+14.3%
Q2 2016+17.6%+16.2%+12.2%
Q1 2016-21.8%
Q4 2015+18.9%
Q3 2015+14.0%
Q2 2015+0.8%
Q1 2015+14.6%
Q4 2014-1.7%
Q3 2014+6.4%
Q2 2014+2.6%
Q1 2014-13.1%
Q4 2013-4.3%
Q3 2013+8.9%
Q2 2013+3.3%
Q1 2013+7.7%
Q4 2009+0.2%
Q4 2012-11.0%
Q3 2012+1.7%
Q2 2012+12.5%
Q1 2012+4.1%
Q4 2011+2.0%
Q3 2010-6.8%
Q3 2011-6.8%
Q2 2010-15.6%
Q1 2011-15.6%
Q2 2011-15.6%
Q4 2010-15.6%
Q1 2010+4.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro